PP
Therapeutic Areas
Qureator Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Metastatic Cancer Target/Combination Discovery | Metastatic Cancers (e.g., Lung, Gastric, Pancreatic) | Discovery/Preclinical |
| Cancer Immunotherapy (vTIME) | Immunotherapy-resistant Tumors | Discovery/Preclinical |
| SillaJen Collaboration | Not Specified | IND Approved |